首页 > 最新文献

Current Cardiology Reviews最新文献

英文 中文
Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease. Volatilome:缺血性心脏病风险评分的新工具
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-08 DOI: 10.2174/011573403X304090240705063536
Basheer Abdullah Marzoog

Developing a novel risk score for accurate assessment of cardiovascular disease (CVD) morbidity and mortality is an urgent need in terms of early prevention and diagnosis and, thereafter, management, particularly of ischemic heart disease. The currently used scores for the evaluation of cardiovascular disease based on the classical risk factors suffer from severe limitations, including inaccurate predictive values. Therefore, we suggest adding a novel non-classical risk factor, including the level of specific exhaled volatile organic compounds that are associated with ischemic heart disease, to the SCORE2 and SCORE2-OP algorithms. Adding these nonclassical risk factors can be used together with the classical risk factors (gender, smoking, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, arterial hypertension, ethnicity, etc.) to develop a new algorithm and further program to be used widely.

为准确评估心血管疾病(CVD)的发病率和死亡率而开发一种新型风险评分,是早期预防、诊断和治疗(尤其是缺血性心脏病)的迫切需要。目前使用的基于传统风险因素的心血管疾病评估评分存在严重的局限性,包括预测值不准确。因此,我们建议在 SCORE2 和 SCORE2-OP 算法中增加一个新的非经典风险因素,包括与缺血性心脏病相关的特定呼出挥发性有机化合物水平。加入这些非经典风险因素后,可与经典风险因素(性别、吸烟、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、糖尿病、动脉高血压、种族等)一起使用,从而开发出一种新的算法和进一步的程序,并得到广泛应用。
{"title":"Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease.","authors":"Basheer Abdullah Marzoog","doi":"10.2174/011573403X304090240705063536","DOIUrl":"https://doi.org/10.2174/011573403X304090240705063536","url":null,"abstract":"<p><p>Developing a novel risk score for accurate assessment of cardiovascular disease (CVD) morbidity and mortality is an urgent need in terms of early prevention and diagnosis and, thereafter, management, particularly of ischemic heart disease. The currently used scores for the evaluation of cardiovascular disease based on the classical risk factors suffer from severe limitations, including inaccurate predictive values. Therefore, we suggest adding a novel non-classical risk factor, including the level of specific exhaled volatile organic compounds that are associated with ischemic heart disease, to the SCORE2 and SCORE2-OP algorithms. Adding these nonclassical risk factors can be used together with the classical risk factors (gender, smoking, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, arterial hypertension, ethnicity, etc.) to develop a new algorithm and further program to be used widely.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Brucellosis with Multivalvular Endocarditis and Complete Heart Block. 布鲁氏菌病并发多瓣心内膜炎和完全性心脏传导阻滞的罕见病例
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-03 DOI: 10.2174/011573403X290326240703100925
Sunil Kumar Gothwal, Kanika Goyal, Ajay Shankar Garg, Bharat Kumar Sahu, Mohit Agrawal, Anurag Mishra, Yogendra Singh, Vetriselvan Subramaniyan, Neelam Singla, Md Sadique Hussain, Gaurav Gupta

Background: Brucellosis is a public health concern that affects multiple organs. However, cardiovascular problems arise infrequently, affecting fewer than 2% of cases, typically presenting as endocarditis.

Case presentation: A 50-year male was admitted with low-grade fever, night sweats, weight loss (13 kg), malaise, and generalized weakness for the past 6 months. On clinical examination, he was febrile with 39.0°C, an average heart rate of 54 bpm, and 100/40 mmHg blood pressure. On cardiovascular examination, S1 and S2 were soft with pan systolic murmur present in the mitral area, and the early diastolic murmur was present in the left third intercostal space. Electrocardiography was suggestive of third-degree heart block with AV dissociation. Transthoracic echocardiography showed mobile vegetations attached to multiple valves- an aortic valve (18.2x11.9mm) and a mitral valve (2.9x7.5mm) with perivalvular abscess. He was given oral doxycycline (100mg B.D.) and rifampicin (600mg/day); the patient responded, but the AV block did not resolve.

Conclusion: This report has drawn attention to multivalvular involvement and cardiac rhythm abnormalities in Brucellosis (in this case, A.V. dissociation was present) because early diagnosis and treatment can cause a significant decrease in morbidity as well as mortality by appropriate treatment.

背景:布鲁氏菌病是一种影响多个器官的公共卫生问题。然而,心血管问题并不常见,发病率不到 2%,通常表现为心内膜炎:一名 50 岁的男性因低烧、盗汗、体重下降(13 公斤)、乏力和全身无力入院,病程已有 6 个月。经临床检查,他发热 39.0°C,平均心率 54 bpm,血压 100/40 mmHg。心血管检查时,S1 和 S2 软,二尖瓣区出现泛发性收缩期杂音,左侧第三肋间隙出现早期舒张期杂音。心电图提示三度心脏传导阻滞伴房室解离。经胸超声心动图显示,多个瓣膜上附着有移动性植被--一个主动脉瓣(18.2x11.9毫米)和一个二尖瓣(2.9x7.5毫米),并伴有瓣周脓肿。患者口服多西环素(100 毫克 B.D.)和利福平(600 毫克/天),病情有所好转,但房室传导阻滞仍未缓解:本报告引起了人们对布鲁氏菌病中多瓣膜受累和心律异常(本例中出现了房室解离)的关注,因为早期诊断和治疗可通过适当的治疗显著降低发病率和死亡率。
{"title":"A Rare Case of Brucellosis with Multivalvular Endocarditis and Complete Heart Block.","authors":"Sunil Kumar Gothwal, Kanika Goyal, Ajay Shankar Garg, Bharat Kumar Sahu, Mohit Agrawal, Anurag Mishra, Yogendra Singh, Vetriselvan Subramaniyan, Neelam Singla, Md Sadique Hussain, Gaurav Gupta","doi":"10.2174/011573403X290326240703100925","DOIUrl":"https://doi.org/10.2174/011573403X290326240703100925","url":null,"abstract":"<p><strong>Background: </strong>Brucellosis is a public health concern that affects multiple organs. However, cardiovascular problems arise infrequently, affecting fewer than 2% of cases, typically presenting as endocarditis.</p><p><strong>Case presentation: </strong>A 50-year male was admitted with low-grade fever, night sweats, weight loss (13 kg), malaise, and generalized weakness for the past 6 months. On clinical examination, he was febrile with 39.0°C, an average heart rate of 54 bpm, and 100/40 mmHg blood pressure. On cardiovascular examination, S1 and S2 were soft with pan systolic murmur present in the mitral area, and the early diastolic murmur was present in the left third intercostal space. Electrocardiography was suggestive of third-degree heart block with AV dissociation. Transthoracic echocardiography showed mobile vegetations attached to multiple valves- an aortic valve (18.2x11.9mm) and a mitral valve (2.9x7.5mm) with perivalvular abscess. He was given oral doxycycline (100mg B.D.) and rifampicin (600mg/day); the patient responded, but the AV block did not resolve.</p><p><strong>Conclusion: </strong>This report has drawn attention to multivalvular involvement and cardiac rhythm abnormalities in Brucellosis (in this case, A.V. dissociation was present) because early diagnosis and treatment can cause a significant decrease in morbidity as well as mortality by appropriate treatment.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141497373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward. 心血管疾病终生风险评估:是时候向前迈进了。
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-03 DOI: 10.2174/011573403X311031240703080650
Evangelia G Sigala, Demosthenes B Panagiotakos

Over the past decades, there has been a notable increase in the risk of Cardiovascular Disease (CVD), even among younger individuals. Policymakers and the health community have revised CVD prevention programs to include younger people in order to take these new circumstances into account. A variety of CVD risk assessment tools have been developed in the past years with the aim of identifying potential CVD candidates at the population level; however, they can hardly discriminate against younger individuals at high risk of CVD.Therefore, in addition to the traditional 10-year CVD risk assessment, lifetime CVD risk assessment has recently been recommended by the American Heart Association/American College of Cardiology and the European Society of Cardiology prevention guidelines, particularly for young individuals. Methodologically, the benefits of these lifetime prediction models are the incorporation of left truncation observed in survival curves and the risk of competing events which are not considered equivalent in the common survival analysis. Thus, lifetime risk data are easily understandable and can be utilized as a risk communication tool for Public Health surveillance. However, given the peculiarities behind these estimates, structural harmonization should be conducted in order to create a sex-, race-specific tool that is sensitive to accurately identifying individuals who are at high risk of CVD. In this review manuscript, we present the most commonly used lifetime CVD risk tools, elucidate several methodological and critical points, their limitations, and the rationale behind their integration into everyday clinical practice.

在过去的几十年中,心血管疾病(CVD)的风险明显增加,甚至在年轻人中也是如此。政策制定者和卫生界已经修订了心血管疾病预防计划,将年轻人纳入其中,以便将这些新情况考虑在内。因此,除了传统的 10 年心血管疾病风险评估外,美国心脏协会/美国心脏病学会和欧洲心脏病学会的预防指南最近还建议进行终生心血管疾病风险评估,尤其是针对年轻人。从方法学上讲,这些终生预测模型的优点在于纳入了生存曲线中观察到的左截断和竞争事件风险,而这些在普通生存分析中并不被视为等同的。因此,终生风险数据易于理解,可用作公共卫生监测的风险交流工具。然而,考虑到这些估计值背后的特殊性,应进行结构协调,以创建一个针对不同性别和种族的工具,该工具应能准确识别心血管疾病高危人群。在这篇综述手稿中,我们介绍了最常用的终生心血管疾病风险工具,阐明了几种方法和关键点、它们的局限性以及将它们纳入日常临床实践的理由。
{"title":"Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward.","authors":"Evangelia G Sigala, Demosthenes B Panagiotakos","doi":"10.2174/011573403X311031240703080650","DOIUrl":"https://doi.org/10.2174/011573403X311031240703080650","url":null,"abstract":"<p><p>Over the past decades, there has been a notable increase in the risk of Cardiovascular Disease (CVD), even among younger individuals. Policymakers and the health community have revised CVD prevention programs to include younger people in order to take these new circumstances into account. A variety of CVD risk assessment tools have been developed in the past years with the aim of identifying potential CVD candidates at the population level; however, they can hardly discriminate against younger individuals at high risk of CVD.Therefore, in addition to the traditional 10-year CVD risk assessment, lifetime CVD risk assessment has recently been recommended by the American Heart Association/American College of Cardiology and the European Society of Cardiology prevention guidelines, particularly for young individuals. Methodologically, the benefits of these lifetime prediction models are the incorporation of left truncation observed in survival curves and the risk of competing events which are not considered equivalent in the common survival analysis. Thus, lifetime risk data are easily understandable and can be utilized as a risk communication tool for Public Health surveillance. However, given the peculiarities behind these estimates, structural harmonization should be conducted in order to create a sex-, race-specific tool that is sensitive to accurately identifying individuals who are at high risk of CVD. In this review manuscript, we present the most commonly used lifetime CVD risk tools, elucidate several methodological and critical points, their limitations, and the rationale behind their integration into everyday clinical practice.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141497340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiology and Neurophysiological Stimulation of Internet Gaming Disorders: A Systematic Review. 网络游戏障碍的心脏病学和神经生理学刺激:系统综述》。
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-21 DOI: 10.2174/011573403X295560240530104352
Immaculate Joy Selvam

Background: Internet Gaming Disorder (IGD) is recognized as a mental health condition associated with excessive video gaming, leading to functional impairments. The inclusion of IGD in the DSM-5 has underscored the importance of comprehensively understanding its physiological and psychological effects.

Objective: This systematic review aims to analyze and synthesize existing literature on the cardiophysiological and neurophysiological activities of individuals diagnosed with IGD, with a focus on identifying patterns, trends, and implications for clinical practice and future research.

Methods: A systematic search was conducted in PubMed and Scopus databases to identify relevant studies published up to 2023. The search strategy included terms related to IGD, cardiophysiology, neurophysiology, and relevant measurement techniques. Inclusion criteria encompassed peer-reviewed research articles and clinical trials examining cardiophysiological (e.g., heart rate variability, blood pressure) and neurophysiological (e.g., brain imaging, electroencephalography) parameters in individuals with IGD. Exclusion criteria were applied to ensure methodological rigor and relevance to the research question.

Results: The initial search yielded 1320 papers related to IGD, of which twenty studies met the eligibility criteria and were included in the review. Data extraction and synthesis focused on key cardiophysiological and neurophysiological outcomes observed in individuals with IGD compared to healthy controls. Findings revealed decreased Heart Rate Variability (HRV), increased sympathetic activity, and executive control deficits in IGD individuals based on Electrocardiogram (ECG) recordings and cognitive assessments. Neuroimaging studies demonstrated heightened brain activation in the lateral and prefrontal cortex, altered reward processing, and impulse control mechanisms among IGD subjects. Gender-specific differences were noted, with males exhibiting distinct thalamic activation striatum and decreased Regional Homogeneity (ReHo) in the right Posterior Cingulate (rPCC) compared to females.

Discussion: The synthesized evidence indicates a complex interplay between excessive gaming and cardiophysiological/neurophysiological changes, highlighting the need for multidimensional assessments in diagnosing and managing IGD. Implications for clinical practice include early detection using ECG, EEG, and advanced neuroimaging techniques, as well as personalized interventions tailored to individual characteristics and gender-specific differences.

Conclusion: This systematic review provides a comprehensive overview of the cardiophysiological and neurophysiological activities associated with Internet Gaming Disorder. The findings underscore the need for further research to elucidate underlying mechanisms, develop standardized diagnostic protocol

背景:网络游戏障碍(Internet Gaming Disorder,IGD)被认为是一种与过度视频游戏有关的精神疾病,会导致功能障碍。IGD被纳入DSM-5后,强调了全面了解其生理和心理影响的重要性:本系统性综述旨在分析和归纳有关被诊断为 IGD 患者的心脏生理和神经生理活动的现有文献,重点是确定模式、趋势以及对临床实践和未来研究的影响:在 PubMed 和 Scopus 数据库中进行了系统检索,以确定截至 2023 年发表的相关研究。搜索策略包括与 IGD、心脏生理学、神经生理学和相关测量技术相关的术语。纳入标准包括经同行评审的研究文章和临床试验,这些文章和试验检查了 IGD 患者的心脏生理学(如心率变异性、血压)和神经生理学(如脑成像、脑电图)参数。为确保方法的严谨性和与研究问题的相关性,采用了排除标准:初步检索结果显示,有 1320 篇论文与 IGD 相关,其中有 20 项研究符合资格标准并被纳入综述。数据提取和综合的重点是与健康对照组相比,在 IGD 患者身上观察到的主要心脏生理学和神经生理学结果。研究结果显示,根据心电图(ECG)记录和认知评估,IGD 患者的心率变异性(HRV)降低,交感神经活动增加,执行控制能力不足。神经影像学研究表明,IGD 受试者的大脑外侧和前额叶皮层激活增强,奖赏处理和冲动控制机制发生改变。研究还发现了性别差异,与女性相比,男性丘脑激活纹状体明显,右侧后扣带回(rPCC)区域同质性(ReHo)降低:综合证据表明,过度游戏与心脏生理/神经生理变化之间存在复杂的相互作用,这凸显了在诊断和管理 IGD 时进行多维评估的必要性。对临床实践的启示包括利用心电图、脑电图和先进的神经影像学技术进行早期检测,以及根据个体特征和性别差异采取个性化干预措施:本系统综述全面概述了与网络游戏障碍相关的心脏生理和神经生理活动。研究结果强调了进一步研究的必要性,以阐明潜在机制、制定标准化诊断方案并优化针对 IGD 患者的干预措施。
{"title":"Cardiology and Neurophysiological Stimulation of Internet Gaming Disorders: A Systematic Review.","authors":"Immaculate Joy Selvam","doi":"10.2174/011573403X295560240530104352","DOIUrl":"10.2174/011573403X295560240530104352","url":null,"abstract":"<p><strong>Background: </strong>Internet Gaming Disorder (IGD) is recognized as a mental health condition associated with excessive video gaming, leading to functional impairments. The inclusion of IGD in the DSM-5 has underscored the importance of comprehensively understanding its physiological and psychological effects.</p><p><strong>Objective: </strong>This systematic review aims to analyze and synthesize existing literature on the cardiophysiological and neurophysiological activities of individuals diagnosed with IGD, with a focus on identifying patterns, trends, and implications for clinical practice and future research.</p><p><strong>Methods: </strong>A systematic search was conducted in PubMed and Scopus databases to identify relevant studies published up to 2023. The search strategy included terms related to IGD, cardiophysiology, neurophysiology, and relevant measurement techniques. Inclusion criteria encompassed peer-reviewed research articles and clinical trials examining cardiophysiological (e.g., heart rate variability, blood pressure) and neurophysiological (e.g., brain imaging, electroencephalography) parameters in individuals with IGD. Exclusion criteria were applied to ensure methodological rigor and relevance to the research question.</p><p><strong>Results: </strong>The initial search yielded 1320 papers related to IGD, of which twenty studies met the eligibility criteria and were included in the review. Data extraction and synthesis focused on key cardiophysiological and neurophysiological outcomes observed in individuals with IGD compared to healthy controls. Findings revealed decreased Heart Rate Variability (HRV), increased sympathetic activity, and executive control deficits in IGD individuals based on Electrocardiogram (ECG) recordings and cognitive assessments. Neuroimaging studies demonstrated heightened brain activation in the lateral and prefrontal cortex, altered reward processing, and impulse control mechanisms among IGD subjects. Gender-specific differences were noted, with males exhibiting distinct thalamic activation striatum and decreased Regional Homogeneity (ReHo) in the right Posterior Cingulate (rPCC) compared to females.</p><p><strong>Discussion: </strong>The synthesized evidence indicates a complex interplay between excessive gaming and cardiophysiological/neurophysiological changes, highlighting the need for multidimensional assessments in diagnosing and managing IGD. Implications for clinical practice include early detection using ECG, EEG, and advanced neuroimaging techniques, as well as personalized interventions tailored to individual characteristics and gender-specific differences.</p><p><strong>Conclusion: </strong>This systematic review provides a comprehensive overview of the cardiophysiological and neurophysiological activities associated with Internet Gaming Disorder. The findings underscore the need for further research to elucidate underlying mechanisms, develop standardized diagnostic protocol","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT-derived Fractional Flow Reserve: How, When, and Where to use this Novel Cardiac Imaging Tool. CT 导出的分数血流储备:如何、何时、何地使用这一新型心脏成像工具。
IF 1.9 Q2 Medicine Pub Date : 2024-06-04 DOI: 10.2174/011573403X300384240529124517
Roozbeh Narimani Javid, Seyed Kianoosh Hosseini

Fractional flow reserve computed tomography (FFRCT) is a novel imaging modality. It utilizes computational fluid dynamics analysis of coronary blood flow obtained from CCTA images to estimate the decrease in pressure across coronary stenosis during the maximum hyperemia. The FFRCT can serve as a valuable tool in the assessment of coronary artery disease (CAD). This non-invasive option can be used as an alternative to the invasive fractional Flow Reserve (FFR) evaluation, which is presently considered the gold standard for evaluating the physiological significance of coronary stenoses. It can help in several clinical situations, including Assessment of Acute and stable chest pain, virtual planning for coronary stenting, and treatment decision-making. Although FFRCT has demonstrated potential clinical applications as a non-invasive imaging technique, it is also crucial to acknowledge its limitations in clinical practice. As a result, it is imperative to meticulously evaluate the advantages and drawbacks of FFRCT individually and contemplate its application in combination with other diagnostic examinations and clinical data.

分数血流储备计算机断层扫描(FFRCT)是一种新型成像模式。它利用从 CCTA 图像中获得的冠状动脉血流的计算流体动力学分析来估算最大充血时冠状动脉狭窄处压力的下降。FFRCT 可作为评估冠状动脉疾病(CAD)的重要工具。这种无创方法可以替代有创的分数血流储备(FFR)评估,后者目前被认为是评估冠状动脉狭窄生理意义的黄金标准。它可以在多种临床情况下提供帮助,包括急性和稳定型胸痛的评估、冠状动脉支架植入术的虚拟规划和治疗决策。尽管 FFRCT 作为一种无创成像技术已被证明具有潜在的临床应用价值,但承认它在临床实践中的局限性也是至关重要的。因此,必须仔细评估 FFRCT 的优缺点,并考虑将其与其他诊断检查和临床数据结合应用。
{"title":"CT-derived Fractional Flow Reserve: How, When, and Where to use this Novel Cardiac Imaging Tool.","authors":"Roozbeh Narimani Javid, Seyed Kianoosh Hosseini","doi":"10.2174/011573403X300384240529124517","DOIUrl":"https://doi.org/10.2174/011573403X300384240529124517","url":null,"abstract":"<p><p>Fractional flow reserve computed tomography (FFRCT) is a novel imaging modality. It utilizes computational fluid dynamics analysis of coronary blood flow obtained from CCTA images to estimate the decrease in pressure across coronary stenosis during the maximum hyperemia. The FFRCT can serve as a valuable tool in the assessment of coronary artery disease (CAD). This non-invasive option can be used as an alternative to the invasive fractional Flow Reserve (FFR) evaluation, which is presently considered the gold standard for evaluating the physiological significance of coronary stenoses. It can help in several clinical situations, including Assessment of Acute and stable chest pain, virtual planning for coronary stenting, and treatment decision-making. Although FFRCT has demonstrated potential clinical applications as a non-invasive imaging technique, it is also crucial to acknowledge its limitations in clinical practice. As a result, it is imperative to meticulously evaluate the advantages and drawbacks of FFRCT individually and contemplate its application in combination with other diagnostic examinations and clinical data.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141261521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Review of Herbal Interventions for the Management of Cardiovascular Diseases. 草药干预治疗心血管疾病的系统回顾。
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-03 DOI: 10.2174/011573403X286573240422104647
Ankita Wal, Neha Verma, Senthil Kumar Balakrishnan, Vinod Gahlot, Sumeet Dwivedi, Pankaj Kumar Sahu, Mohammad Tabish, Pranay Wal

Background: Cardiovascular diseases represent a significant global health burden, necessitating diverse approaches for effective management. Herbal interventions have gained attention as potential adjuncts or alternatives to conventional therapies due to their perceived safety and therapeutic potential. This structured abstract provides a comprehensive review of herbal interventions for the management of CVDs, summarising key findings, mechanisms of action, and clinical implications.

Objective: This systematic review aims to evaluate the impact of various herbal interventions employed for managing cardiovascular diseases.

Method: We conducted an extensive literature search across electronic databases, including PubMed, Scopus, and Web of Science, from inception to 2022. Studies were included if they investigated the use of herbal remedies for preventing or treating CVDs. Data extraction and synthesis focused on botanical sources, active compounds, mechanisms of action, and clinical outcomes.

Result: Numerous herbal interventions have demonstrated promising cardiovascular benefits. A number of medicinal herbs well identified to treat CVD are Moringaoleifera, Ginseng, Ginkgo biloba, Celosia argentea, Gongronematrifolium, Gynostemmapentaphyllum, Bombaxceiba, Gentianalutea, Allium sativum, Crataegusspp, Curcuma longa, Camellia sinensis, and Zingiberofficinale. Mechanistic insights reveal that herbal interventions often target multiple pathways involved in CVD pathogenesis. These mechanisms encompass anti-inflammatory, antioxidant, anti-thrombotic, anti-hypertensive, and lipid-lowering effects. Additionally, some herbs enhance endothelial function, promote nitric oxide production, and exert vasodilatory effects, contributing to improved cardiovascular health. Clinical studies have provided evidence of the efficacy of certain herbal interventions in reducing CVD risk factors and improving patient outcomes. However, more rigorous, large-scale clinical trials are needed to establish their long-term safety and effectiveness. It is crucial to consider potential herb-drug interactions and standardise dosages for reliable therapeutic outcomes.

Conclusion: This comprehensive review highlights the potential of herbal interventions as valuable adjuncts or alternatives for managing cardiovascular diseases. Herbal remedies offer diverse mechanisms of action, targeting key CVD risk factors and pathways. While promising, their clinical utility warrants further investigation through well-designed trials to establish their safety and efficacy, paving the way for integrated approaches to cardiovascular disease management. Healthcare providers and patients should engage in informed discussions about the use of herbal interventions alongside conventional therapies in the context of CVD prevention and treatment.

背景:心血管疾病给全球健康带来了沉重负担,需要采取多种方法进行有效治疗。草药干预作为传统疗法的潜在辅助或替代疗法,因其安全性和治疗潜力而备受关注。本结构式摘要全面综述了治疗心血管疾病的草药干预措施,总结了主要发现、作用机制和临床意义:本系统综述旨在评估用于治疗心血管疾病的各种草药干预措施的影响:我们在电子数据库(包括 PubMed、Scopus 和 Web of Science)中进行了广泛的文献检索,时间跨度从开始到 2022 年。凡是调查使用草药预防或治疗心血管疾病的研究均被纳入。数据提取和综合侧重于植物来源、活性化合物、作用机制和临床结果:结果:许多草药干预措施已证明对心血管有益。经确认可治疗心血管疾病的草药有:Moringaoleifera、人参、银杏叶、青葙子、Gongronematrifolium、Gynostemmapentaphyllum、Bombaxceiba、Gentianalutea、Allium sativum、Crataegusspp、Curcuma longa、Camellia sinensis 和 Zingiberofficinale。机理研究表明,草药干预通常针对心血管疾病发病机制中的多种途径。这些机制包括抗炎、抗氧化、抗血栓、抗高血压和降血脂作用。此外,一些草药还能增强内皮功能,促进一氧化氮的产生,发挥扩张血管的作用,有助于改善心血管健康。临床研究证明,某些草药干预措施在降低心血管疾病风险因素和改善患者预后方面具有疗效。然而,还需要更严格的大规模临床试验来确定其长期安全性和有效性。关键是要考虑到草药与药物之间潜在的相互作用,并规范剂量,以获得可靠的治疗效果:本综述强调了草药干预作为治疗心血管疾病的重要辅助手段或替代方法的潜力。中草药的作用机制多种多样,可针对心血管疾病的关键风险因素和途径。虽然前景广阔,但仍需通过精心设计的试验进一步研究其临床效用,以确定其安全性和有效性,为心血管疾病的综合管理方法铺平道路。在预防和治疗心血管疾病的过程中,医疗服务提供者和患者应在知情的情况下讨论在使用传统疗法的同时使用草药干预的问题。
{"title":"A Systematic Review of Herbal Interventions for the Management of Cardiovascular Diseases.","authors":"Ankita Wal, Neha Verma, Senthil Kumar Balakrishnan, Vinod Gahlot, Sumeet Dwivedi, Pankaj Kumar Sahu, Mohammad Tabish, Pranay Wal","doi":"10.2174/011573403X286573240422104647","DOIUrl":"10.2174/011573403X286573240422104647","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases represent a significant global health burden, necessitating diverse approaches for effective management. Herbal interventions have gained attention as potential adjuncts or alternatives to conventional therapies due to their perceived safety and therapeutic potential. This structured abstract provides a comprehensive review of herbal interventions for the management of CVDs, summarising key findings, mechanisms of action, and clinical implications.</p><p><strong>Objective: </strong>This systematic review aims to evaluate the impact of various herbal interventions employed for managing cardiovascular diseases.</p><p><strong>Method: </strong>We conducted an extensive literature search across electronic databases, including PubMed, Scopus, and Web of Science, from inception to 2022. Studies were included if they investigated the use of herbal remedies for preventing or treating CVDs. Data extraction and synthesis focused on botanical sources, active compounds, mechanisms of action, and clinical outcomes.</p><p><strong>Result: </strong>Numerous herbal interventions have demonstrated promising cardiovascular benefits. A number of medicinal herbs well identified to treat CVD are Moringaoleifera, Ginseng, Ginkgo biloba, Celosia argentea, Gongronematrifolium, Gynostemmapentaphyllum, Bombaxceiba, Gentianalutea, Allium sativum, Crataegusspp, Curcuma longa, Camellia sinensis, and Zingiberofficinale. Mechanistic insights reveal that herbal interventions often target multiple pathways involved in CVD pathogenesis. These mechanisms encompass anti-inflammatory, antioxidant, anti-thrombotic, anti-hypertensive, and lipid-lowering effects. Additionally, some herbs enhance endothelial function, promote nitric oxide production, and exert vasodilatory effects, contributing to improved cardiovascular health. Clinical studies have provided evidence of the efficacy of certain herbal interventions in reducing CVD risk factors and improving patient outcomes. However, more rigorous, large-scale clinical trials are needed to establish their long-term safety and effectiveness. It is crucial to consider potential herb-drug interactions and standardise dosages for reliable therapeutic outcomes.</p><p><strong>Conclusion: </strong>This comprehensive review highlights the potential of herbal interventions as valuable adjuncts or alternatives for managing cardiovascular diseases. Herbal remedies offer diverse mechanisms of action, targeting key CVD risk factors and pathways. While promising, their clinical utility warrants further investigation through well-designed trials to establish their safety and efficacy, paving the way for integrated approaches to cardiovascular disease management. Healthcare providers and patients should engage in informed discussions about the use of herbal interventions alongside conventional therapies in the context of CVD prevention and treatment.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Reflexes - Vagus as the Key Player. 心血管反射--迷走神经是关键角色。
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-29 DOI: 10.2174/011573403X284831240408053528
Shantala S Herlekar, Ashwini R Doyizode, Savitri P Siddangoudra, Anupama V

The cardiac and vascular systems work in coordination by activating various reflex mechanisms based on the body's needs. These may be during physiological variations or pathophysiological changes seen in disease conditions of varying degrees of severity. This article intends to explain various reflexes involved in the homeostasis of the cardiovascular system and the role of vagus as the key component in all these reflexes. The article also explains the components of the reflex arc, the stimulus and response, and the role of reflex in a few diseases. This article describes 22 different cardiovascular reflexes in detail.

心脏和血管系统根据身体需要启动各种反射机制,从而协调工作。这可能是在生理变化期间,也可能是在不同程度的疾病情况下出现的病理生理变化。本文旨在解释心血管系统平衡所涉及的各种反射,以及迷走神经作为所有这些反射的关键组成部分所起的作用。文章还解释了反射弧的组成部分、刺激和反应以及反射在一些疾病中的作用。本文详细介绍了 22 种不同的心血管反射。
{"title":"Cardiovascular Reflexes - Vagus as the Key Player.","authors":"Shantala S Herlekar, Ashwini R Doyizode, Savitri P Siddangoudra, Anupama V","doi":"10.2174/011573403X284831240408053528","DOIUrl":"10.2174/011573403X284831240408053528","url":null,"abstract":"<p><p>The cardiac and vascular systems work in coordination by activating various reflex mechanisms based on the body's needs. These may be during physiological variations or pathophysiological changes seen in disease conditions of varying degrees of severity. This article intends to explain various reflexes involved in the homeostasis of the cardiovascular system and the role of vagus as the key component in all these reflexes. The article also explains the components of the reflex arc, the stimulus and response, and the role of reflex in a few diseases. This article describes 22 different cardiovascular reflexes in detail.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140849834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial Thrombus or Atrial Myxoma? Preliminary Analysis of Echocardiographic Findings of a Case Series. 心房血栓还是心房肌瘤?一个病例系列的超声心动图结果初步分析。
IF 2.4 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-25 DOI: 10.2174/011573403X281926240417110330
Guobing Hu, Fang Song

Background: Echocardiography has been proven to be a useful tool for detecting atrial- occupying lesions, ranging from primary or secondary tumors to thrombi. Although the precise diagnosis is important as clinical treatment modalities differ, sometimes differentiating a thrombus from a myxoma is very difficult.

Case report: From January 2019 to December 2022, we retrospectively analyzed the echocardiographic findings of 8 patients who were found to have an interatrial mass. Of the 8 patients, 4 had a right atrial mass, and 4 had a left atrial mass. Based on ultrasonic examination, the initial diagnosis was a thrombus and the second diagnosis was a myxoma for all 8 patients. All masses were finally confirmed to be thrombi. Although an echocardiogram can provide significant information on the nature of atrial masses in many patients, qualitative diagnosis of a small percentage of atrial masses remains difficult.

Conclusion: An atrial thrombus is occasionally difficult to differentiate from an atrial myxoma in patients without atrial fibrillation, especially when it is not attached to the left atrial appendage. Upon review of the echocardiographic findings of the 8 patients described in our study, it is essential to highlight the fact that a thrombus can mimic a myxoma and thereby create a diagnostic conundrum.

背景:超声心动图已被证明是检测心房占位性病变(从原发性或继发性肿瘤到血栓)的有效工具。虽然精确诊断非常重要,因为临床治疗方法各不相同,但有时很难区分血栓和肌瘤:自2019年1月至2022年12月,我们回顾性分析了8例发现房室间肿块患者的超声心动图检查结果。在这 8 名患者中,4 人患有右心房肿块,4 人患有左心房肿块。根据超声波检查,8 名患者的初步诊断均为血栓,第二诊断为肌瘤。所有肿块最终都被证实为血栓。虽然超声心动图能为许多患者提供有关心房肿块性质的重要信息,但对一小部分心房肿块的定性诊断仍然存在困难:结论:在无心房颤动的患者中,心房血栓偶尔很难与心房肌瘤相鉴别,尤其是当血栓未附着于左心房阑尾时。回顾我们研究中描述的 8 位患者的超声心动图结果,有必要强调一个事实,即心房血栓可以模拟肌瘤,从而造成诊断难题。
{"title":"Atrial Thrombus or Atrial Myxoma? Preliminary Analysis of Echocardiographic Findings of a Case Series.","authors":"Guobing Hu, Fang Song","doi":"10.2174/011573403X281926240417110330","DOIUrl":"10.2174/011573403X281926240417110330","url":null,"abstract":"<p><strong>Background: </strong>Echocardiography has been proven to be a useful tool for detecting atrial- occupying lesions, ranging from primary or secondary tumors to thrombi. Although the precise diagnosis is important as clinical treatment modalities differ, sometimes differentiating a thrombus from a myxoma is very difficult.</p><p><strong>Case report: </strong>From January 2019 to December 2022, we retrospectively analyzed the echocardiographic findings of 8 patients who were found to have an interatrial mass. Of the 8 patients, 4 had a right atrial mass, and 4 had a left atrial mass. Based on ultrasonic examination, the initial diagnosis was a thrombus and the second diagnosis was a myxoma for all 8 patients. All masses were finally confirmed to be thrombi. Although an echocardiogram can provide significant information on the nature of atrial masses in many patients, qualitative diagnosis of a small percentage of atrial masses remains difficult.</p><p><strong>Conclusion: </strong>An atrial thrombus is occasionally difficult to differentiate from an atrial myxoma in patients without atrial fibrillation, especially when it is not attached to the left atrial appendage. Upon review of the echocardiographic findings of the 8 patients described in our study, it is essential to highlight the fact that a thrombus can mimic a myxoma and thereby create a diagnostic conundrum.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease. 管理心血管疾病的新兴治疗策略综述。
IF 1.9 Q2 Medicine Pub Date : 2024-04-16 DOI: 10.2174/011573403X299265240405080030
Minal Narkhede, Avinash Pardeshi, Rahul Bhagat, Gajanan Dharme
Cardiovascular disease (CVD) remains a foremost global health concern, necessitating ongoing exploration of innovative therapeutic strategies. This review surveys the latest developments in cardiovascular therapeutics, offering a comprehensive overview of emerging approaches poised to transform disease management. The examination begins by elucidating the current epidemiological landscape of CVD and the economic challenges it poses to healthcare systems. It proceeds to scrutinize the limitations of traditional therapies, emphasizing the need for progressive interventions. The core focus is on novel pharmacological interventions, including advancements in drug development, targeted therapies, and repurposing existing medications. The burgeoning field of gene therapy and its potential in addressing genetic predispositions to cardiovascular disorders are explored, alongside the integration of artificial intelligence and machine learning in risk assessment and treatment optimization. Non-pharmacological interventions take center stage, with an exploration of digital health technologies, wearable devices, and telemedicine as transformative tools in CVD management. Regenerative medicine and stem cell therapies, offering promises of tissue repair and functional recovery, are investigated for their potential impact on cardiac health. This review also delves into the interplay of lifestyle modifications, diet, exercise, and behavioral changes, emphasizing their pivotal role in cardiovascular health and disease prevention. As precision medicine gains prominence, this synthesis of emerging therapeutic modalities aims to guide clinicians and researchers in navigating the dynamic landscape of cardiovascular disease management, fostering a collective effort to alleviate the global burden of CVD and promote a healthier future.
心血管疾病(CVD)仍然是全球首要的健康问题,需要不断探索创新的治疗策略。这篇综述调查了心血管治疗学的最新发展,全面概述了有望改变疾病管理的新兴方法。研究首先阐明了心血管疾病目前的流行病学状况及其对医疗保健系统带来的经济挑战。接着,它仔细研究了传统疗法的局限性,强调了渐进式干预的必要性。核心重点是新型药物干预,包括药物开发、靶向治疗和现有药物再利用方面的进展。此外,还探讨了新兴的基因治疗领域及其在解决心血管疾病遗传倾向方面的潜力,以及人工智能和机器学习在风险评估和治疗优化方面的整合。非药物干预占据中心位置,探讨了数字健康技术、可穿戴设备和远程医疗作为心血管疾病管理的变革性工具。再生医学和干细胞疗法有望实现组织修复和功能恢复,本综述对其对心脏健康的潜在影响进行了研究。本综述还深入探讨了生活方式调整、饮食、运动和行为改变之间的相互作用,强调了它们在心血管健康和疾病预防中的关键作用。随着精准医学的日益突出,这篇关于新兴治疗模式的综述旨在指导临床医生和研究人员驾驭心血管疾病管理的动态景观,促进减轻心血管疾病的全球负担和促进更健康未来的共同努力。
{"title":"Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease.","authors":"Minal Narkhede, Avinash Pardeshi, Rahul Bhagat, Gajanan Dharme","doi":"10.2174/011573403X299265240405080030","DOIUrl":"https://doi.org/10.2174/011573403X299265240405080030","url":null,"abstract":"Cardiovascular disease (CVD) remains a foremost global health concern, necessitating ongoing exploration of innovative therapeutic strategies. This review surveys the latest developments in cardiovascular therapeutics, offering a comprehensive overview of emerging approaches poised to transform disease management. The examination begins by elucidating the current epidemiological landscape of CVD and the economic challenges it poses to healthcare systems. It proceeds to scrutinize the limitations of traditional therapies, emphasizing the need for progressive interventions. The core focus is on novel pharmacological interventions, including advancements in drug development, targeted therapies, and repurposing existing medications. The burgeoning field of gene therapy and its potential in addressing genetic predispositions to cardiovascular disorders are explored, alongside the integration of artificial intelligence and machine learning in risk assessment and treatment optimization. Non-pharmacological interventions take center stage, with an exploration of digital health technologies, wearable devices, and telemedicine as transformative tools in CVD management. Regenerative medicine and stem cell therapies, offering promises of tissue repair and functional recovery, are investigated for their potential impact on cardiac health. This review also delves into the interplay of lifestyle modifications, diet, exercise, and behavioral changes, emphasizing their pivotal role in cardiovascular health and disease prevention. As precision medicine gains prominence, this synthesis of emerging therapeutic modalities aims to guide clinicians and researchers in navigating the dynamic landscape of cardiovascular disease management, fostering a collective effort to alleviate the global burden of CVD and promote a healthier future.","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140696901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices. 耐用左心室辅助装置的抗血栓治疗 "少即是多"。
IF 1.9 Q2 Medicine Pub Date : 2024-04-15 DOI: 10.2174/011573403X307310240404062647
Matthew T Brown, Nanette K Wenger
{"title":"Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices.","authors":"Matthew T Brown, Nanette K Wenger","doi":"10.2174/011573403X307310240404062647","DOIUrl":"https://doi.org/10.2174/011573403X307310240404062647","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140702541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Cardiology Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1